Fresenius Medical Care has successfully completed its merger with NxStage Medical, Inc.

More Info

NxStage Kidney Care Opens Dialysis Center in Parkland, Florida

Dialysis provider brings flexible therapy options to Boca Raton area

LAWRENCE, Mass. – (April 30, 2015) NxStage® Kidney Care, Inc. (NxKC), a subsidiary of NxStage® Medical, Inc. (Nasdaq: NXTM), today announced the opening of a new dialysis center in Parkland, Florida. Like the Company’s other Florida centers located in Jacksonville and Orlando, NxKC Parkland offers patients with renal failure flexible and customized therapy options managed by a team of highly trained nurses and medical professionals.

Patients and their care partners receive comprehensive, individualized training for all home therapies offered at the center. The new facility features the NxStage System One™ for several of the therapies provided, including home hemodialysis (HHD), home nocturnal hemodialysis, flexible in-center hemodialysis, and short-term respite care. In addition, the center offers peritoneal dialysis (PD) and transplant assistance.

“Our team at NxStage Kidney Care Parkland partners with patients and their loved ones to customize therapy according to their individual healthcare and lifestyle goals,” said Dr. Sergio Vega, Medical Director at NxKC Parkland. “Our goal is to help patients feel confident and comfortable from the moment they walk in.”

Patients meet with a dedicated renal social worker who helps them navigate the transplant process, and also provides advice for balancing treatments with their lifestyle goals. A registered renal dietitian works with patients to build personalized nutrition plans to support their health needs. The Parkland center has a warm and welcoming reception area and a state-of-the-art treatment area that includes massaging chairs, wireless internet access and private dedicated training areas to provide additional comfort and convenience to patients and their families.

“NxStage is offering Boca Raton-area patients the opportunity to learn about and take advantage of our flexible approach to dialysis treatment,” said Robert Brown, President of NxStage Kidney Care. “We’re committed to improving the standard of care for dialysis patients in Florida, and we invite all local patients to visit our center to find out how we can help them get back to doing more of the things they want to do.”

For more information please call (561) 370-6290 or visit

NxStage Kidney Care Parkland
7525 North State Road 7
Parkland, FL
(561) 370-6290

About NxStage Kidney Care

NxStage Kidney Care, Inc., a subsidiary of NxStage Medical, Inc. (Nasdaq: NXTM), is innovating a dialysis care model that is intended to support and encourage patient centered care and provide enhanced access to the life-changing benefits of home therapy as well as flexible in-center options. By leveraging NxStage's home leadership and the innovative technology of its System One, NxStage Kidney Care is committed to helping patients take control of their dialysis and to allowing physicians the flexibility to prescribe what is truly best for their patients. For more information, please visit or call (866) 694-2707.

About NxStage Medical

NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of ESRD and acute kidney failure. For more information on NxStage and its products, please visit the Company's website at

Forward-Looking Statements

This release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words “anticipate,” “believe,” “expect,” “estimate,” “plan,” and similar expressions are generally intended to identify forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors including those that are discussed in NxStage's filings with the Securities and Exchange Commission, including the Quarterly Report on Form 10-K for the quarter ended December 31, 2014. NxStage is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.

Media contact:
Kristen K. Sheppard, Esq.
Tel: (978) 332-5923